Client News

Affluent Medical Takes Stock of its Recent Operational Advances

Pentixapharm Holding AG, a Subsidiary of Eckert & Ziegler SE, Plans IPO on the Prime Standard of the Frankfurt Stock Exchange

TVM Capital Life Science to Participate in LSI EUROPE ’24 Emerging Medtech Summit 2024

Syntekabio Appoints Joonhyuk Choi, Former Target Health CEO, as Head of US Operations

Sofinnova Partners appoints Karl Naegler as Partner

Abivax Presents First-Half 2024 Financial Results

Secarna Pharmaceuticals will Present Data at 6th Inflammasome Therapeutics Summit Demonstrating the Potential of ASOs to Target the Expression of NLRP3

Syntekabio to Highlight its Cutting-edge AI-driven Discovery Solutions at BioTechX

Medigene AG Announces U.S. FDA Clearance of IND Application for MDG1015, a First-in-Class, Third Generation T Cell Receptor Engineered T Cell (TCR-T) Therapy for Multiple Solid Tumor Indications

Secarna Establishes Scientific Advisory Board with Leading Oncology Experts Prof. Dr. Eggermont and Prof. Dr. Zippelius